Article Information
History
- July 19, 2024.
Article Versions
- Version 1 (March 20, 2023 - 10:43).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Bruno Bockorny1,2,*,
- Lakshmi Muthuswamy3,*,
- Ling Huang4,*,
- Marco Hadisurya5,
- Christine Maria Lim6,
- Leo L. Tsai2,7,
- Ritu R. Gill2,7,
- Jesse L. Wei2,7,
- Andrea J. Bullock1,2,
- Joseph E. Grossman9,
- Robert J. Besaw1,
- Supraja Narasimhan9,
- W. Andy Tao5,
- Sofia Perea1,
- Mandeep S. Sawhney2,10,
- Steven D. Freedman2,10,
- Manuel Hidalgo11,12,*,
- Anton Iliuk13,*,† and
- Senthil K. Muthuswamy14,*,†
- 1Division of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA
- 2Harvard Medical School, Boston, MA, USA
- 3Blueprint Medicines, Cambridge, MA, USA
- 4Henry Ford Cancer Institute, Detroit, MI, USA
- 5Department of Biochemistry, Purdue University, West Lafayette, IN, USA
- 6Nanyang Technological University, Singapore
- 7Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA
- 8Agenus Inc, Lexington, MA, USA
- 9Deciphera Pharmaceuticals, Waltham, MA, USA
- 10Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA
- 11Division of Hematology-Oncology, Weill Cornell Medical College, New York, NY, USA
- 12New York-Presbyterian Hospital, New York, NY, USA
- 13Tymora Analytical Operations, West Lafayette, IN, USA
- 14National Cancer Institute, NIH, Bethesda, MD, USA
- ↵†Corresponding authors Correspondence:
Senthil K. Muthuswamy PhD Laboratory of Cancer Biology and Genetics LCBG, Bldg. 37, Rm4068, 37 Convent Dr. Bethesda, MD 20892 |Ph:240-858-7734 Senthil.muthuswamy{at}nih.gov Anton Iliuk PhD 1201 Cumberland Ave, Suite 209, West Lafayette, IN 47906 anton.iliuk{at}tymora-analytical.com
↵* Equal contribution